List of Vaccines: to be Updated
Members of the Expert Council under the President of Russia consider it necessary to approve a list of immunobiological drugs to be manufactured in Russia.
Preliminary variant of the list has already been developed by the Ministry of Health in cooperation with other institutions. According to experts, some of its provisions require update to account for financial-economical and social efficacy parameters. Besides, members of the Expert Council suggest that as the updates are considered the appropriateness of manufacture of specific vaccines in Russia from the point of view of feasibility of step by step manufacture localization and technology transfer be assessed.
Members of the Expert Council also believe, that before a specific vaccine, e.g. a measles, rubella and varicella vaccine is included into the list, the need for the demand for it should be assessed, as the volume of demand for these products is not currently defined. It is necessary to assess the cost effectiveness of local manufacture.
Besides, experts are not confident in the need to include rare and exotic vaccines into the list. They think that before taking a decision on expensive manufacture of such products in Russia, social and economical consequences of investments in the expensive production should be assess, and epidemiological justification of the choice of vaccines should be made.
If it is done, than, according to experts, the document will be a significant step forward in the field of stimulation of state of art vaccine manufacture promotion in the Russian Federation.